{{各地中文名|cn=丹曲林、丹曲洛林、胆罗啉、旦著能|tw=單挫林|hk=|mo=}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 459436942
| IUPAC_name = 1-<nowiki/>{[5-(4-nitrophenyl)-2-furyl]methylideneamino}<br>imidazolidine-2,4-dione
| image = Dantrolene Tanaka et al.svg
| alt = Structural formula of dantrolene
| width = 250
| image2 = Dantrolene 3D spacefill.png
| alt2 = Space-filling model of the dantrolene molecule
<!--Clinical data-->
| tradename = Dantrium<br/>Dantrolen<br/>Dantamacrin
| Drugs.com = {{drugs.com|monograph|dantrium}}
| pregnancy_US = C
| legal_status =  
| routes_of_administration = [[口服|口服]]、[[靜脈注射|靜脈注射]]
<!--Pharmacokinetic data-->
| bioavailability = 70%
| protein_bound =  
| metabolism = [[肝|肝]]
| elimination_half-life =  
| excretion = [[膽管|膽管]]、[[腎|腎]]
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 7261-97-4
| ATC_prefix = M03
| ATC_suffix = CA01
| ATC_supplemental =  
| PubChem = 2952
| IUPHAR_ligand = 4172
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01219
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2847
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = F64QU97QCR
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D02347
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 4317
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201288
<!--Chemical data-->
| C=14 | H=10 | N=4 | O=5
| molecular_weight = 314.253 g/mol
| smiles = [O-][N+](=O)c3ccc(c2oc(C=NN1C(=O)NC(=O)C1)cc2)cc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H10N4O5/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22/h1-7H,8H2,(H,16,19,20)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OZOMQRBLCMDCEG-UHFFFAOYSA-N
}}<!--
[[File:DantroleneSodiumSalt.JPG|thumb]]-->
'''單挫林'''是一種突觸後[[肌肉鬆弛劑|肌肉鬆弛劑]]，可減輕[[骨骼肌|骨骼肌]]的[[肌肉收缩|收缩]]。它透過抑制[[蘭諾定受體|蘭諾定受體]]（Ryanodine receptor）來阻止從[[肌質網|肌質網]]釋放[[鈣離子|鈣離子]]以達成治療效果<ref>{{cite journal|last1=Zucchi|first1=R|last2=Ronca-Testoni|first2=S|title=The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states.|journal=Pharmacological reviews|date=March 1997|volume=49|issue=1|pages=1–51|pmid=9085308}}</ref>。單挫林用來治療和預防因全身麻醉而引發罕見致命的[[恶性高热|恶性高热]]的主要藥物。早期恶性高热的死亡率高達70%，使用丹曲林其死亡率已低於5%。

單挫林也用於{{le|抗精神藥物惡性症候群|neuroleptic malignant syndrome}}（{{lang|en|neuroleptic malignant syndrome}}，NMS）管理，或是肌肉[[痙攣|痙攣]]（例如[[中風|中風]]、{{le|截癱|Paraplegia}}、[[腦麻痺|腦性麻痺]]、疼痛伴隨[[多发性硬化症|多发性硬化症]]）<ref>{{cite journal|last1=Pinder|first1=RM|last2=Brogden|first2=RN|last3=Speight|first3=TM|last4=Avery|first4=GS|title=Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.|journal=Drugs|date=January 1977|volume=13|issue=1|pages=3–23|pmid=318989|doi=10.2165/00003495-197713010-00002}}</ref>，或用於[[2,4-二硝基苯酚|2,4-二硝基苯酚]]中毒時{{r|Krause}}<ref>{{cite journal | vauthors = Kumar S, Barker K, Seger D | year = 2002 | title = Dinitrophenol-Induced Hyperthermia Resolving With Dantrolene Administration. Abstracts of the North American Congress of Clinical Toxicology | url = | journal = Clin Toxicol | volume = 40 | issue = | pages = 599–673 | doi=10.1081/clt-120016859}}</ref><ref name="pmid16749560">{{cite journal |vauthors=Barker K, Seger D, Kumar S |title=Comment on "Pediatric fatality following ingestion of Dinitrophenol: postmortem identification of a 'dietary supplement'" |journal=Clin Toxicol (Phila) |volume=44 |issue=3 |pages=351 |year=2006 |pmid=16749560 |doi= 10.1080/15563650600584709|url=}}</ref>。另外，如{{le|達諾殺|Dinoseb}}（或稱「地樂酚」，一般為殺蟲劑、除草劑）、{{le|特乐酚|Dinoterb}}等相關化合物<ref name=Krause>{{cite journal |vauthors=Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F |title=Dantrolene – a review of its pharmacology, therapeutic use and new developments |journal=Anaesthesia |volume=59 |issue=4 |pages=364–73 |year=2004 |pmid=15023108 |doi=10.1111/j.1365-2044.2004.03658.x | url=http://www.blackwell-synergy.com/doi/full/10.1111/j.1365-2044.2004.03658.x}}</ref>。

截至2015年，美國典型藥物治療費用為100至200美元<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=2}}</ref>；在台灣，該藥物一劑的成本為新台幣5000元。<ref>{{Cite web|url=http://health.businessweekly.com.tw/AArticle.aspx?ID=ARTL000022578&p=3|title=麻醉醫師的噩夢─惡性高熱》一個醫師看《麻醉風暴》有感：別為了省錢不顧人命！|accessdate=2017-11-04|author=白映俞, 劉育志|date=2015-04-27|publisher=商業週刊}}</ref>

== 瓶裝 ==
{{gallery|width=
|File:Dantrolene Ampoule.JPG|Dantrolen（歐洲包裝）
|File:DantroleneSodiumSalt.JPG|Dantrolene Sodium Salt<br/>單挫林的鈉鹽是橙色結晶固體。
}}
==參考文獻==
{{reflist}}

==外部連結==
{{commonscat|Dantrolene}}
* [http://www.kompendium.ch/MonographieTxt.aspx?lang=de&MonType=fi{{dead link|date=2017年12月 |bot=InternetArchiveBot |fix-attempted=yes }} Swiss Drug Compendium on oral Dantrolene]{{德語}}

[[Category:呋喃|Category:呋喃]]
[[Category:乙内酰脲|Category:乙内酰脲]]
[[Category:肌肉鬆弛劑|Category:肌肉鬆弛劑]]
[[Category:硝基苯|Category:硝基苯]]